共 50 条
- [1] Stellungnahme zur „Kuba-Therapie“ bei tapetoretinalen Degenerationen (Retinitis pigmentosa)Stellungnahme der Deutschen Ophthalmologischen Gesellschaft, des Berufsverbandes der Augenärzte Deutschlands, der Retinologischen Gesellschaft und des Arbeitskreises Klinische Fragen der Pro Retina Deutschland e. V., Stand November 2022Statement on “Cuba treatment” of tapetoretinal degeneration (retinitis pigmentosa)Statement of the German Society of Ophthalmology, the German Professional Association of Ophthalmologists, the German Retina Society and the Working Group on Clinical Issues of the Pro Retina Deutschland e.V., status November 2022 Die Ophthalmologie, 2023, 120 (4) : 378 - 379
- [4] Statement of the German Ophthalmological Society, the German Retina Society, and the Professional Association of Ophthalmologists in Germany on treatment of diabetic macular edema OPHTHALMOLOGE, 2021, 118 (SUPPL 1): : 40 - 67
- [5] Supplementary statement on IVOM drugs for the treatment of diabetic macular edema with foveal involvement Statement of the German Society of Ophthalmology (DOG), the German Retina Society (RG) and the German Professional Association of Ophthalmologists (BVA). Status 28 October 2022 OPHTHALMOLOGIE, 2023, 120 (03): : 273 - 275
- [6] Supplementary Statement on IVOM Drugs for the Treatment of Diabetic Macular Edema with Foveal Involvement Statement of the German Society of Ophthalmology (DOG), the German Retina Society (RG) and the German Professional Association of Ophthalmologists (BVA). Status 28 October 2022 KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2023, 240 (03) : 327 - 331